In addition to invasion and migration, glutamate stimulates tumor growth, proliferation, and survival of glioma cells through the EGFR-phospho-Akt and PI3K/AKT pathways (Schunemann et al., 2010; Prickett and Samuels, 2012). This evidence concerns the gene EGFR and central nervous system cancer.